SD

Srimanta Das

Active Director Director DIN 10406157
DIN 10406157 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Srimanta Das

Data last updated:

Srimanta Das is a Director at Bescheiden Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Bescheiden Pharmaceuticals Private Limited reported revenue of ₹28 Lakh (FY 2025).

DIN 10406157
Primary Designation Director
Industry Pharma
First Appointment 28 Nov 2023
Oldest Company Age 2 yrs
Largest company Bescheiden Pharmaceuticals Private Limited · ₹28 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Nov 20232023₹28 Lakh (FY 2025)Active

Board colleagues of Srimanta Das

NameDINCompanyDesignation
Nayanjyoti Kalita10406156Bescheiden Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bescheiden Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Srimanta Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srimanta Das

Srimanta Das currently holds 1 directorship: Bescheiden Pharmaceuticals Private Limited (Director, since 28 Nov 2023, revenue ₹28 Lakh (FY 2025)).

Srimanta Das was first appointed on 28 Nov 2023 as Director at Bescheiden Pharmaceuticals Private Limited.

The current boards of Srimanta Das's companies include Nayanjyoti Kalita (Bescheiden Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available